Ladenburg Thalmann analyst Aydin Huseynov downgrades Calithera Biosciences (NASDAQ:CALA) from Buy to Neutral.
Ladenburg Thalmann Downgrades Calithera Biosciences to Neutral
Ladenburg Thalmann analyst Aydin Huseynov downgrades Calithera Biosciences (NASDAQ:CALA) from Buy to Neutral.
Related Posts
Analyst Ratings for SciPlay
Within the last quarter, SciPlay (NASDAQ:SCPL) has observed the following analyst ratings:
Norfolk Southern Announces Additional Paid Sick Leave Agreements With Mechanical And Engineering Railroaders Over 1,350 Craft Railroaders To Receive New Sick Leave Benefit
Over 1,350 craft railroaders to receive new sick leave benefit
ATLANTA, March 14, 2023 /PRNewswire/ -- Norfolk Southern Corporation (NYSE:NSC) announced Tuesday that it has reached agreements with two more of
What 15 Analyst Ratings Have To Say About 3M
Over the past 3 months, 15 analysts have published their opinion on 3M (NYSE:MMM) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.